Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck loses effort to dismiss 24 Fosamax cases
Reuters
Monday, December 14, 2009 - 11:18am
tags:
Merck, Fosamax, lawsuits
AstraZeneca Loses A Patent Battle Over Crestor
Pharmalot
Monday, December 14, 2009 - 11:17am
tags:
patents, Crestor, AstraZeneca
Roche-ImmunoGen to Start T-DM1 Trials
TheStreet.com
Monday, December 14, 2009 - 11:16am
tags:
Roche, Immunogen, clinical trials, breast cancer
Allergan CEO sounds off on Botox tax
Marketwatch
Monday, December 14, 2009 - 7:38am
tags:
Allergan, Botox, Botax bill, Pharma CEOs, David Pyott
Merck KGaA Sticks to Pharmaceuticals Strategy, Handelsblatt Says
Bloomberg
Monday, December 14, 2009 - 7:37am
tags:
Merck KGaA
Glaxo Said to Have Paid $1 Billion to Settle Paxil Lawsuits
Bloomberg
Monday, December 14, 2009 - 7:35am
tags:
Paxil, lawsuits, settlements, GSK
Merck Starts China Trial of Cancer Vaccine
Seeking Alpha
Monday, December 14, 2009 - 7:34am
tags:
cancer, Merck, China, vaccines, Stimuvax
FDA Launches Orphan Drug Workshop at KGI
PR NewsWire
Sunday, December 13, 2009 - 12:22pm
tags:
FDA, orphan drugs
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
PR-Canada
Sunday, December 13, 2009 - 12:13pm
tags:
Roche, Genentech, Biogen Idec, ocrelizumab
Targacept Initiates Phase 2 Study Of TC-5619 In Cognitive Dysfunction In Schizophrenia
Medical News Today
Sunday, December 13, 2009 - 12:12pm
tags:
schizophrenia
Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer Patients
Earth Times
Sunday, December 13, 2009 - 12:08pm
tags:
Array Biopharma, breast cancer, ovarian cancer, gastric cancer
The Historical Success of Growing Big Pharma from Small
Seeking Alpha
Sunday, December 13, 2009 - 12:04pm
tags:
Big Pharma
Bristol Myers' Mead Johnson Swap: Good Deal or Smarter to Wait?
Seeking Alpha
Sunday, December 13, 2009 - 12:02pm
tags:
Bristol-Myers Squibb, Mead Johnson
Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options
Yahoo/BusinessWire
Sunday, December 13, 2009 - 12:01pm
tags:
Pfizer
Going to bat for tax-free Botox
MarketWatch
Sunday, December 13, 2009 - 12:00pm
tags:
Botox
Why Cell-Enriched Fat Grafting is Safe & Effective: New Mechanistic Support in Preclinical Model
Yahoo/BusinessWire
Saturday, December 12, 2009 - 1:38pm
tags:
Cytori
Hope for Advanced Thymic Cancer Patients as International Study Begins
Med India, India
Saturday, December 12, 2009 - 1:35pm
tags:
Thymic Cancer
Taro again warns shareholders to stay away from Sun
domain-b
Saturday, December 12, 2009 - 1:32pm
tags:
Taro, Sun Pharma
Drug makers quicker to embrace settlements to delay low-cost generics
bizjournals
Saturday, December 12, 2009 - 1:29pm
tags:
generics
Algeta Announces First US Patient Randomized In ALSYMPCA Phase III Study At Tulane Cancer Center, New Orleans
Medical News Today
Saturday, December 12, 2009 - 1:28pm
tags:
Algeta, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.